GSK Handed $106M Verdict For Paxil Generic Contract Breach
A New Jersey federal jury on Tuesday slapped GlaxoSmithKline LLC with a $106.7 million verdict for allegedly breaching an exclusive contract with Mylan Inc. by allowing Apotex Inc. to sell generic...To view the full article, register now.
Already a subscriber? Click here to view full article